CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 8-K Event Delisting notice · Bylaws or fiscal year change · Other events
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results
- 4 Open-market buy Director bought 196,851 shares at $0.03 ($5,000)
- 4 Open-market buy CEO & President bought 1,968,504 shares at $0.03 ($50,000)
- 4 Open-market buy Director bought 1,968,504 shares at $0.03 ($50,000)
- 4 Open-market buy CEO & President bought 41,000 shares at $0.06 ($2,583)
- 8-K Event Delisting notice · Other events
- 4 Open-market buy COO, Secretary, Gen. Counsel bought 500 shares at $0.09 ($44)
- 8-K Event Material agreement
- UPLOAD Other SEC-generated Letter
- DEF 14A Proxy Proxy Statement
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 4 Grant or award Director acquired 44,899 shares (grant or award)
- 4 Grant or award Director acquired 44,899 shares (grant or award)
- 4 Grant or award Director acquired 44,899 shares (grant or award)
- 4 Open-market buy CEO & President bought 50,000 shares at $0.13 ($6,730)
- 4 Open-market buy CEO & President bought 44,000 shares at $0.12 ($5,060)
- 4 Grant or award Director acquired 19,290 shares (grant or award)
Page 6 of 82 · 1,636 filings